Although some of the data on the role of CCR5 in the pathogenesis of MS and EAE appears to be conflicting, the weight of evidence identifies CCR5 as an active participant in the recruitment of inflammatory cells from the circulation, promoting tissue injury in MS and EAE lesions. The gene discussed is CCR5; the disease is myeloid sarcoma.